Integrated Analyses Identify a Master Microrna Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer.
Da Yang,Yan Sun,Limei Hu,Hong Zheng,Ping Ji,Chad V. Pecot,Yinjiao Zhao,Sheila M. Reynolds,Hanyin Cheng,Rajesha Rupaimoole,David Cogdell,Matti Nykter,Russell R. Broaddus,Cristian Rodriguez‐Aguayo,Gabriel Lopez‐Berestein,Jinsong Liu,Ilya Shmulevich,Anil K. Sood,Kexin Chen,Wei Zhang
DOI: https://doi.org/10.1016/j.ccr.2012.12.020
IF: 50.3
2013-01-01
Cancer Cell
Abstract:(Cancer Cell 23, 186–199; February 11, 2013) We regret that we failed to acknowledge the unpublished data provided by Bagnoli et al. in our paper. The case material first reported by Bagnoli et al. (Oncotarget, 2012) was part of Table 1. The unpublished clinical follow-up data was generously provided by the authors and used for the curve shown in Figure 6E in our paper. The correct text on page 193 of the original article should be as follows: “To further confirm miR-506’s association with good prognosis in ovarian cancer, we obtained two miRNAs microarray data sets from GEO and ArrayExpress (Bentink Data set and Bagnoli Data set, Table 1) with 129 and 55 OvCa cases, respectively. In both data sets, miR-506 expression is significantly associated with longer progression-free survival (Bagnoli et al., personal communication) (log-rank p = 0.02 and 0.0006 for Bentink and Bagnoli Data sets, respectively, Figures 6D and 6E).” We would like to apologize for this oversight and sincerely thank the authors for providing this unpublished data to our study. Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian CancerYang et al.Cancer CellFebruary 11, 2013In BriefIntegrated genomic analyses revealed a miRNA-regulatory network that further defined a robust integrated mesenchymal subtype associated with poor overall survival in 459 cases of serous ovarian cancer (OvCa) from The Cancer Genome Atlas and 560 cases from independent cohorts. Eight key miRNAs, including miR-506, miR-141, and miR-200a, were predicted to regulate 89% of the targets in this network. Follow-up functional experiments illustrate that miR-506 augmented E-cadherin expression, inhibited cell migration and invasion, and prevented TGFβ-induced epithelial-mesenchymal transition by targeting SNAI2, a transcriptional repressor of E-cadherin. Full-Text PDF Open Archive